At-School Vaccination Boosts HPV Vaccination Coverage
By Lori Solomon HealthDay Reporter
THURSDAY, May 30, 2024 -- At-school vaccination may be a useful tool to increase human papillomavirus (HPV) vaccination coverage among adolescents, according to a study published online May 23 in JAMA Network Open.
Nathalie Thilly, Ph.D., from Université de Lorraine in Nancy, France, and colleagues examined the effectiveness of a three-component intervention (education of adolescents and their parents, the training of providers, and free vaccination at school) on HPV vaccination coverage among adolescents (aged 11 to 14 years). The analysis included 30,739 adolescents.
The researchers found that the median vaccination coverage increased by 4.0 to 14.2 percentage points at two months after the intervention. There was a significant increase in vaccination coverage with at-school vaccination (5.50 percentage points). There was no effect on vaccine coverage with adolescents’ education and motivation (−0.08 percentage points) and general practitioners' (GPs') training (−1.46 percentage points). At-school vaccination had a higher effect when access to GPs was poor.
"Regarding the primary outcome, it is possible that the time horizon was too short to highlight the benefits of the education and motivation and GPs' training components," the authors write. "They require that parents schedule two visits with their GP (one for the vaccine prescription and one for the vaccination) and they may delay one or both visits until they have another reason to consult their GP."
Several authors disclosed ties to pharmaceutical companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
No Link Found Between COVID-19 Vaccination During Pregnancy and Spontaneous Abortion
THURSDAY, May 15, 2025 -- There is no association between COVID-19 vaccination in pregnancy and spontaneous abortion, according to a study published online May 2...
RSV Vaccines, Nirsevimab Tied to Reduced RSV-Linked Hospitalization
TUESDAY, May 13, 2025 -- Maternal respiratory syncytial virus (RSV) vaccination and nirsevimab were associated with a reduction in RSV-associated hospitalization rates among...
Combined Flu, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults
FRIDAY, May 9, 2025 -- mRNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines against several influenza strains and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.